Morphea, an unusual side effect of anti-TNF-alpha treatment.
Mattozzi
Carlo
C
Richetta
Antonio Giovanni
AG
Cantisani
Carmen
C
Giancristoforo
Simona
S
D'Epiro
Sara
S
Gonzalez Serva
Aldo
A
Viola
Franca
F
Cucchiara
Salvatore
S
Calvieri
Stefano
S
D000068879:Adalimumab; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D012393:Rosacea / Q000188:drug therapy* / Q000473:pathology; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000175:diagnosis; D012867:Skin / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab